Procognia Limited Signs Distribution and Marketing License Agreement with Leading Life Science Japanese Company – CTCLS

TEL AVIV, Israel--(BUSINESS WIRE)--Procognia announced today that, on July 11th, 2011, the company signed an agreement with CTC Laboratory System Corporation (CTCLS). According to this agreement, Procognia will grant CTCLS a non-exclusive license to sell, distribute and market the glycoanalysis product, the GlycoScope™ in Japan. CTCLS will receive some percentage from the revenue based on agreed transfer price between the companies. CTCLS will be responsible for all the sales and marketing activities of the GlycoScope™ and will bare all the costs relating to these activities in Japan.